BIOVASCULAR
BioVascular is a clinical stage privately held biotechnology company developing รขโฌลfirst in classรขโฌย products for platelet mediated cardiovascular diseases. BioVascularรขโฌโขs initial product, saratin, is a polypeptide produced by recombinant means in yeast. This product was discovered by and licensed from Merck KGaA. BioVascular is conducting human clinical trials of saratin for use in hemodialysis access graft and peripheral artery grafts to reduce intimal hyperplasia, which can lead to failure of the graft.
BIOVASCULAR
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.biovascularinc.com
Total Employee:
1+
Status:
Active
Contact:
858-455-5000
Email Addresses:
[email protected]
Total Funding:
10.87 M USD
Technology used in webpage:
Nginx GoDaddy SSL Shockwave Flash Embed Nginx 1.16 Intermedia Media Temple MediaTemple DNS
Current Advisors List
Investors List
BB Biotech Ventures
BB Biotech Ventures investment in Series C - BioVascular
Domain Associates
Domain Associates investment in Series C - BioVascular
Merck
Merck investment in Series C - BioVascular
Official Site Inspections
http://www.biovascularinc.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
